Before a manufacturer places a sourcing order or a supplier agrees to a distribution arrangement, they want to understand how the commercial relationship actually functions. That is a reasonable requirement, and this page answers it directly.
Equihealth FZCO operates on a Bill-to Ship-to trading model. This is a recognised structure in international pharmaceutical commerce and the basis of every transaction Equihealth conducts. The explanation below covers what the model is, how the documentation works, what it means for each party, and why this structure is used in cross-border pharmaceutical trading.
The Bill-to Ship-to model is a commercial trading arrangement involving three parties: the supplier, the trading company, and the end buyer. Goods move directly from the supplier to the end buyer. Equihealth sits between them commercially — not physically.
The supplier issues its invoice to Equihealth. Equihealth issues its own invoice to the end buyer. Two invoices, one physical shipment. This is not a complex or unusual structure. It is standard practice among professional pharmaceutical intermediaries operating in cross-border trade.